Celcuity Inc.
CELC- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001603454
In the last 90 days, Celcuity Inc. insiders filed 0 open-market purchases and 1 sale; 273 institutions reported holding it in 13F filings for Q2 2026, worth $5.95B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Celcuity Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 41 | 1 | 30 | −10 |
| Shares | 4.67M | 731.8K | 4.80M | +857.4K (+21.7%) |
| Value | $42.5M | $6.66M | $48.2M | +$12.3M (+34.3%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Celcuity Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PFM Health Sciences, LP | 140,426 | $1.41M | 0.05% |
Sold out (11)
Institutions that held Celcuity Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Gagnon Advisors, LLC | 181,353 | $1.65M |
| Ergoteles LLC | 46,954 | $427.0K |
| Citadel Advisors LLC | 28,115 | $256.0K |
| Corton Capital Inc. | 22,560 | $205.0K |
| Delphia (USA) Inc. | 21,312 | $194.0K |
| D. E. Shaw & Co., Inc. | 13,202 | $120.0K |
| FMR LLC | 126 | $1.00K |
| New York State Common Retirement Fund | 79 | $1.00K |
| Citigroup Inc | 86 | $1.00K |
| Barclays PLC | 35 | $0 |
| Credit Suisse AG | 5 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Celcuity Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Frontier Wealth Management LLC | 731,800 | $6.66M |